Universal Corp
UVV
42.83
+0.13
+0.30%
Universal Corp
US · UVV
#3205 by market cap
42.83
+0.13
+0.30%
Live - 5344 symbols - heartbeat 301s ago
· 2026-10-08 08:59
Pre-market
42.84
+0.02%
After-hours
42.90
+0.16%
- Market cap
- 1.07B
- P/E (TTM)i
- 56.36
- P/Bi
- 0.77
- EPSi
- 1.30
- Div yieldi
- 7.66%
- 52W posi
- 11%
Reader sentiment
Are you bullish or bearish on UVV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.98, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.77% YoY
Margins
- Gross margin
- 17.51%
- Operating margin
- 7.23%
- Net margin
- 1.12%
Key ratios & quality
- Enterprise valuei
- 1.92B
- Altman Z-Scorei
- 2.98
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 1.91B | 1.98B | 2.10B | 2.57B | 2.75B | 2.95B | 2.92B |
| Gross profit | 406.59M | 356.81M | 386.00M | 408.93M | 458.29M | 536.10M | 548.66M | 512.02M |
| Selling & admin expenses | 225.12M | 222.90M | 219.79M | 240.69M | 277.21M | 310.57M | 305.29M | 300.67M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 181.47M | 133.91M | 166.21M | 168.24M | 181.07M | 225.53M | 243.37M | 211.35M |
| Pretax profit | 151.32M | 113.29M | 125.73M | 142.27M | 141.97M | 164.08M | 154.22M | 102.65M |
| Tax | 41.19M | 35.29M | 29.41M | 38.66M | 11.73M | 31.11M | 40.95M | 46.66M |
| Net profit | 110.13M | 78.00M | 96.31M | 103.60M | 130.24M | 132.97M | 113.27M | 56.00M |
| Basic EPS | 4 | 3 | 4 | 4 | 5 | 5 | 4 | 1 |
| Diluted EPS | 4.11 | 2.86 | 3.53 | 3.47 | 4.97 | 4.78 | 3.78 | 1.30 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 702.28M | 593.76M | 754.18M | 861.29M | 715.24M | 523.78M |
| Gross profit | 116.00M | 114.13M | 139.83M | 159.59M | 98.47M | 83.09M |
| Selling & admin expenses | 73.24M | 79.19M | 72.18M | 76.93M | 72.37M | 80.79M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 42.76M | 34.94M | 67.65M | 82.66M | 26.10M | 2.30M |
| Pretax profit | 20.72M | 19.70M | 46.01M | 66.89M | -29.95M | -12.87M |
| Tax | 6.39M | 5.34M | 11.21M | 25.30M | 4.81M | -4.52M |
| Net profit | 14.33M | 14.37M | 34.80M | 41.59M | -34.76M | -8.35M |
| Basic EPS | 0 | 0 | 1 | 1 | -2 | 0 |
| Diluted EPS | 0.37 | 0.34 | 1.36 | 1.32 | -1.73 | -0.20 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.59B | 1.48B | 1.56B | 1.75B | 1.80B | 2.10B | 2.16B | 1.97B |
| Cash & ST investments | 297.56M | 107.43M | 197.22M | 81.65M | 64.69M | 55.59M | 260.12M | 62.18M |
| Inventory | 699.22M | 806.57M | 786.62M | 1.02B | 1.04B | 1.26B | 995.94M | 1.04B |
| Total assets | 2.13B | 2.12B | 2.34B | 2.59B | 2.64B | 2.94B | 2.99B | 2.77B |
| Total current liabilities | 253.75M | 267.40M | 293.16M | 518.72M | 441.99M | 711.36M | 750.16M | 564.24M |
| Short-term debt | 54.02M | 87.86M | 109.19M | 192.94M | 206.97M | 427.57M | 465.78M | 298.74M |
| Long-term debt | 368.50M | 368.76M | 518.17M | 518.55M | 616.81M | 617.36M | 617.92M | 616.73M |
| Total liabilities | 753,306,000.00 | 831,637,000.00 | 993,499,000.00 | 1,201,576,000.00 | 1,202,230,000.00 | 1,458,316,000.00 | 1,489,014,000.00 | 1,305,643,000.00 |
| Total equity | 1.38B | 1.29B | 1.35B | 1.38B | 1.44B | 1.48B | 1.50B | 1.46B |
| Retained earnings | 1.11B | 1.08B | 1.09B | 1.09B | 1.14B | 1.17B | 1.19B | 1.14B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.16B | 2.35B | 2.24B | 2.18B | 1.97B | 2.24B |
| Cash & ST investments | 260.12M | 178.44M | 88.65M | 85.23M | 62.18M | 173.59M |
| Inventory | 995.94M | 1.42B | 1.36B | 1.20B | 1.04B | 1.37B |
| Total assets | 2.99B | 3.19B | 3.07B | 3.02B | 2.77B | 3.04B |
| Total current liabilities | 750.16M | 942.69M | 828.63M | 751.45M | 564.24M | 870.94M |
| Short-term debt | 465.78M | 632.51M | 551.39M | 473.53M | 298.74M | 577.48M |
| Long-term debt | 617.92M | 618.06M | 618.20M | 616.59M | 616.73M | 616.87M |
| Total liabilities | 1,489,014,000.00 | 1,689,718,000.00 | 1,566,289,000.00 | 1,492,340,000.00 | 1,305,643,000.00 | 1,612,573,000.00 |
| Total equity | 1.50B | 1.50B | 1.50B | 1.53B | 1.46B | 1.42B |
| Retained earnings | 1.19B | 1.17B | 1.19B | 1.20B | 1.14B | 1.11B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 164.52M | 10.90M | 220.41M | 44.88M | -10.56M | -74.63M | 326.97M | 129.10M |
| Depreciation & amortization | 37.10M | 38.38M | 44.73M | 52.52M | 57.30M | 58.33M | 59.77M | 53.44M |
| Free cash flow | 125.76M | -24.33M | 154.26M | -8.32M | -65.23M | -140.65M | 264.37M | 80.27M |
| Dividends paid | -69.88M | -75.37M | -75.18M | -76.44M | -77.39M | -78.40M | -79.69M | -81.30M |
| Stock buybacks / issuance | -1.44M | -33.46M | 0 | -3.05M | -3.45M | -4.74M | 0 | 0 |
| Ending cash balance | 297.56M | 107.43M | 203.22M | 87.65M | 64.69M | 55.59M | 260.12M | 62.18M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 158.75M | -205.10M | 32.75M | 114.32M | 187.14M | -117.12M |
| Depreciation & amortization | 15.22M | 13.58M | 13.62M | 13.01M | 13.23M | 12.76M |
| Free cash flow | 151.03M | -217.16M | 23.70M | 95.12M | 178.61M | -133.05M |
| Dividends paid | -20.02M | -20.02M | -20.41M | -20.44M | -20.44M | -20.44M |
| Stock buybacks / issuance | -- | 0 | -- | -- | -- | -2.75M |
| Ending cash balance | 260.12M | 178.44M | 88.65M | 85.23M | 62.18M | 173.59M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 7.77 | 5.55 | 6.85 | 6.54 | 9.06 | 8.44 | 6.56 | 2.27 |
| ROA %i | 4.84 | 3.37 | 3.92 | 3.51 | 4.75 | 4.29 | 3.21 | 1.13 |
| ROIC %i | 6.59 | 4.83 | 5.77 | 5.26 | 7.57 | 7.15 | 5.96 | 3.09 |
| 5-year avg ROE %i | 6.82 | 6.21 | 5.98 | 6.95 | 7.15 | 7.29 | 7.49 | 6.58 |
| EBIT margin %i | 7.58 | 6.97 | 7.60 | 8.08 | 7.44 | 8.38 | 7.93 | 6.04 |
| FCF / sales %i | 5.65 | -- | 7.78 | -- | -- | -- | 8.97 | 2.74 |
| Current ratioi | 6.26 | 5.53 | 5.31 | 3.37 | 4.08 | 2.96 | 2.87 | 3.49 |
| Quick ratioi | 2.75 | 1.72 | 1.93 | 0.91 | 1.08 | 0.82 | 1.19 | 1.13 |
| Debt / assetsi | 19.81 | 22.75 | 27.63 | 28.65 | 32.18 | 36.23 | 36.94 | 33.97 |
| LT debt / equityi | 27.56 | 31.66 | 41.15 | 40.89 | 45.98 | 44.30 | 43.78 | 45.29 |
| Interest coveragei | 9.64 | 6.71 | 6.04 | 6.13 | 3.88 | 3.48 | 2.94 | 2.39 |
| Revenue CAGR (3Y) %i | 1.65 | -2.67 | -0.84 | -1.88 | 10.40 | 11.49 | 11.90 | 4.40 |
| Net income CAGR (3Y) %i | -1.52 | -12.31 | -6.13 | -5.97 | 20.06 | 11.02 | 3.16 | -35.92 |
| FCF CAGR (3Y) %i | -3.37 | -- | 48.39 | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.56 | 7.20 | 7.72 | 5.81 | 2.27 | 1.34 |
| ROA %i | 3.21 | 3.32 | 3.65 | 2.81 | 1.13 | 0.61 |
| ROIC %i | 5.96 | 5.87 | 6.25 | 5.10 | 3.09 | 2.31 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.93 | 8.58 | 8.38 | 7.80 | 6.04 | 5.00 |
| FCF / sales %i | 8.97 | 4.50 | 5.26 | 1.81 | 2.74 | 5.76 |
| Current ratioi | 2.87 | 2.49 | 2.70 | 2.91 | 3.49 | 2.57 |
| Quick ratioi | 1.19 | 0.77 | 0.78 | 0.96 | 1.13 | 0.72 |
| Debt / assetsi | 36.94 | 39.99 | 38.86 | 36.91 | 33.97 | 40.10 |
| LT debt / equityi | 43.78 | 44.07 | 43.66 | 43.17 | 45.29 | 46.06 |
| Interest coveragei | 2.94 | 3.30 | 3.30 | 3.08 | 2.39 | 1.96 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Tobacco Operations is the largest reported line at 83.46% of revenue, across 2 reported segments.
- The next-largest line, Ingredients Operations, is a distant second at 16.54% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Tobacco Operations83.46%
Ingredients Operations16.54%
Quote time 2026-10-08 08:59:33 · For reference only, not investment advice and not tailored to your situation.